Skip to content

Integrated Multi-Omics and Single-Cell Analyses Identify PCDHGB4 as a Prognostic Biomarker and Oncogenic Regulator in Pan-Squamous Cell Carcinoma

Sep 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 34 references

TL;DR

PCDHGB4 is a potential biomarker for pan-cancer, especially SCC, and may promote tumor progression through oncogenic signaling and modulation of the tumor immune microenvironment.

View source

Similar papers

Open access Sep 2026

HIST1H4L promotes small cell lung cancer tumorigenesis by regulating the PI3K/Akt pathway and serves as a potential diagnostic biomarker

Objective Despite advances in treatment, small cell lung cancer (SCLC) remains highly aggressive and prone to relapse, leading to poor patient outcomes. Histone HIST1H4L is a key protein that maintains chromatin structure, but its role in SCLC is still unclear. This study aims to define its oncogenic role in SCLC and t...

Shi-Cheng Feng, Min Feng, Zhi-Qiang Lu et al. · 0 citations
Open access Sep 2026

Integrated multi-omics analyses reveal the role of PAXX in colorectal cancer progression and the tumor immune microenvironment

PAXX is a DNA double-strand break repair factor involved in classical non-homologous end joining. Although elevated PAXX expression has been reported in colon cancer, its functional role and downstream mechanisms in colorectal cancer (CRC) remain incompletely defined. This study investigated the role of PAXX in CRC p...

Jin-Zhong Cao, Zi-Jing Wang, Xi Luo et al. · 0 citations
Open access Sep 2026

Multi-omics and experimental validation reveal ISG20L2 as a potential pro-oncogenic regulator in gastric cancer

Background Gastric cancer is a major malignancy with molecular heterogeneity and limited biomarkers for risk stratification and therapeutic guidance. Interferon-stimulated 20 kDa exonuclease-like 2 (ISG20L2), a regulator of ribosome biogenesis, has been implicated in tumor progression, but its relevance in gastric canc...

Song Liang, Chuan-Jun Wang, Yong-Kang Liang et al. · 0 citations
Open access 2026

Integrative Multi-Omics and Single-Cell Analyses Identify FKBP10 as a CAF-Associated Biomarker Linked to ECM Remodeling and Aggressiveness in Neuroblastoma

: Objectives: Neuroblastoma (NB) is a heterogeneous pediatric malignancy driven by both intrinsic oncogenic programs and the stromal microenvironment. However, the critical stromal regulators associated with poor prognosis and metastasis in NB remain poorly characterized. This study aimed to identify key cancer-associa...

Zhao-Long Wang, B. Gong, Chao-Yu Wang et al. · 0 citations
Open access Aug 2026

Integrated multi-omics analysis and functional experiments reveals PPAP2C as a potential prognostic biomarker and therapeutic target in breast cancer

PPAP2C exhibits the most significant overexpression pattern across 33 cancer types and was significantly associated with advanced clinical stages and aggressive subtypes (HER2+ and TNBC).

Xiao-Xi Lin, Li-Hang Cen, Si-Hui Yue et al. · 0 citations
Open access Sep 2026

METTL3-mediated m6A modification of RBM39 promotes cancer stemness and tumor progression in head and neck squamous cell carcinoma

RBM39 plays an important regulatory role in multiple cancers. However, its systematic function across pan-cancer and its specific mechanism in head and neck squamous cell carcinoma (HNSC) remain unclear. In this study, we performed pan-cancer expression and survival analyses based on TCGA and GTEx databa...

Yu Xin, Wen-Zhi Deng, Chu-Yang Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.